1 hr 2 min
The Future of Cannabis and Psilocybin as Plant-Based Medicine: A Conversation with Stephen Dahmer and Betty Aldworth – Episode 13 THE 411 ON 420
-
- Business
Millions of Americans are utilizing medical cannabis and psilocybin to treat specific medical conditions each day. However, scientific and medical research in the U.S. lags behind other nations. Dr. Stephen M. Dahmer, Chief Medical Officer at Vireo Health, and Betty Aldworth, Director of Communications and Events at the Multidisciplinary Association for Psychedelic Studies (MAPS) join Perkins Coie senior counsel Andrew Kline to discuss the current dilemma and a path forward. During the podcast, the group discusses the current state of cannabis and psilocybin research, the barriers faced by researchers, and why it is critically important to have people who understand the science involved in policymaking.
Millions of Americans are utilizing medical cannabis and psilocybin to treat specific medical conditions each day. However, scientific and medical research in the U.S. lags behind other nations. Dr. Stephen M. Dahmer, Chief Medical Officer at Vireo Health, and Betty Aldworth, Director of Communications and Events at the Multidisciplinary Association for Psychedelic Studies (MAPS) join Perkins Coie senior counsel Andrew Kline to discuss the current dilemma and a path forward. During the podcast, the group discusses the current state of cannabis and psilocybin research, the barriers faced by researchers, and why it is critically important to have people who understand the science involved in policymaking.
1 hr 2 min